Farmington Hills, MI, November 1, 2017 –EMMA International Consulting Group, Inc. (EMMA International) a global leader in quality, regulatory, and compliance services for the Biotechnology, Pharmaceuticals, and Medical Device industries, has partnered with Impact Analytical, Inc. (Impact Analytical) a fully accredited, independent testing lab providing highly customized service and support to over 300 international customers. Impact Analytical is focused on providing best in class service to customers with demanding needs in the Pharmaceutical, Medical Device, Polymer and Specialty Chemical industries. Impact Analytical is registered by the FDA and licensed by the DEA, along with being accredited to ISO 9001:2015.
“Our partnership with Impact Analytical further solidifies our portfolio of providing a one-stop-shop boutique of services to our clients”, stated Kira Jabri, Vice President and COO. “Additionally, this partnership will help our mutual clients expedite their time to market resulting in reduced costs and a more streamlined pathway”.
“Time to market is everything for our customers, whether they are a startup medical device manufacturer or a Fortune 500 company. This partnership allows us to accelerate the regulatory approval process by streamlining the analytical data exchange process behind the compliance process. For most customers, this will ultimately translate into lower costs too,” stated Neil Chapman, Impact Analytical’s Chief Executive Officer.
EMMA International and Impact Analytical understand that for clients in time-pressured industries, having complementary services work together only results in a positive outcome and a less stressful streamlined process.
